These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8991433)

  • 1. [Infections and granulocyte colony-stimulating factor (G-CSF)].
    Solovera JJ
    Enferm Infecc Microbiol Clin; 1996; 14(7):409-10. PubMed ID: 8991433
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of granulocyte-colony stimulating factor on empiric therapy with flomoxef sodium and tobramycin in febrile neutropenic patients with hematological malignancies. Kan-etsu Hematological Disease and Infection Study Group.
    Yoshida M; Karasawa M; Naruse T; Fukuda M; Hirashima K; Oh H; Ninomiya H; Abe T; Saito K; Shishido H; Moriyama Y; Shibata A; Motoyoshi K; Nagata N; Miura Y
    Int J Hematol; 1999 Feb; 69(2):81-8. PubMed ID: 10071455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filgrastim treatment of HIV-infected patients improves neutrophil function.
    Pitrak DL
    AIDS; 1999; 13 Suppl 2():S25-30. PubMed ID: 10596678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant granulocyte colony-stimulating factor (G-CSF) in infectious diseases: still a debate.
    Wiedermann FJ; Mittermayr M; Hoffmann G; Schobersberger W
    Wien Klin Wochenschr; 2001 Feb; 113(3-4):90-6. PubMed ID: 11253746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutropenia, neutrophil dysfunction, and bacterial infection in patients with human immunodeficiency virus disease: the role of granulocyte colony-stimulating factor.
    Kuritzkes DR
    Clin Infect Dis; 2000 Feb; 30(2):256-60. PubMed ID: 10671324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Granulocyte colony-stimulating factor: its potential role in infectious disease.
    Hartung T
    AIDS; 1999; 13 Suppl 2():S3-9. PubMed ID: 10596675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of bacterial infections in patients with advanced HIV infection.
    Mitsuyasu R
    AIDS; 1999; 13 Suppl 2():S19-23. PubMed ID: 10596677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutrophil growth factors.
    Crawford J
    Curr Hematol Rep; 2002 Nov; 1(2):95-102. PubMed ID: 12901130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status of granulocyte (neutrophil) transfusion therapy for infectious diseases.
    Hübel K; Dale DC; Engert A; Liles WC
    J Infect Dis; 2001 Jan; 183(2):321-328. PubMed ID: 11112098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of two different rG-CSF preparations in the treatment of patients with severe congenital neutropenia.
    Carlsson G; Ahlin A; Dahllöf G; Elinder G; Henter JI; Palmblad J
    Br J Haematol; 2004 Jul; 126(1):127-32. PubMed ID: 15198743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mean myeloperoxidase index in lymphoma transplants receiving recombinant granulocyte-macrophage colony stimulating factor.
    Tsakona CP; Khwaja A; Goldstone AH
    Bone Marrow Transplant; 1993 Apr; 11(4):345-6. PubMed ID: 8387371
    [No Abstract]   [Full Text] [Related]  

  • 12. Kinetics of neutrophil production in normal and neutropenic animals during the response to filgrastim (r-metHu G-CSF) or filgrastim SD/01 (PEG-r-metHu G-CSF).
    Lord BI; Woolford LB; Molineux G
    Clin Cancer Res; 2001 Jul; 7(7):2085-90. PubMed ID: 11448927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD34+ dose-driven administration of granulocyte colony-stimulating factor after high-dose chemotherapy in lymphoma patients.
    Todisco E; Castagna L; Sarina B; Mazza R; Magagnoli M; Balzarotti M; Nozza A; Siracusano L; Timofeeva I; Anastasia A; Demarco M; Santoro A
    Eur J Haematol; 2007 Feb; 78(2):111-6. PubMed ID: 17313558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
    Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, and other immunomodulatory therapies for the treatment of infectious diseases in solid organ transplant recipients.
    Page AV; Liles WC
    Curr Opin Organ Transplant; 2008 Dec; 13(6):575-80. PubMed ID: 19060545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial to assess the value of recombinant human granulocyte colony stimulating factor (R-MeTHuG-CSF, filgrastim) in accelerating the dose rate of chemotherapy for intermediate and high-grade non-Hodgkin's lymphoma (NHL). The Central Lymphoma Group.
    Smith GM; Child JA; Cullen MH; Bailey NP; Woodruffe CM; Fletcher J; Earl H; Barnard D
    Hematol Oncol; 1996 Dec; 14(4):193-201. PubMed ID: 9267465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Granulocyte colony-stimulating factor in the treatment of febrile neutropenia].
    López-Hernández MA; Jiménez-Alvarado R; Borbolla-Escoboza R; de Diego Flores-Chapa J; Alvarado-Ibarra M; González-Avante M; Trueba-Chrysti ME; Anaya-Cuéllar I
    Gac Med Mex; 2000; 136(2):99-105. PubMed ID: 10815320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF.
    Alvarado Ibarra ML; Borbolla Escoboza JR; López-Hernández MA; González-Avante CM; FloresChapa JD; Trueba Christy E; Anaya Cuellar I
    Rev Invest Clin; 1999; 51(2):77-80. PubMed ID: 10410585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic use of colony stimulating factors for established neutropenic fever.
    Walton SM
    W V Med J; 1998; 94(1):26-8. PubMed ID: 9505567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.